{"id":"sevre-long","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL5314789","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By activating the GLP-1 receptor, Sevre-Long™ increases insulin secretion in response to high blood glucose levels, decreases glucagon secretion, and slows gastric emptying, thereby lowering blood glucose levels and promoting weight loss.","oneSentence":"Sevre-Long™ is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the incretin hormone GLP-1 to regulate glucose metabolism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:09.191Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"},{"name":"Obesity"}]},"trialDetails":[{"nctId":"NCT01079117","phase":"PHASE3","title":"Morphine Slow-release Capsules in Substitution Therapy","status":"COMPLETED","sponsor":"Mundipharma Medical Company","startDate":"2006-10","conditions":"Opiate Dependent","enrollment":276}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Sevre-Long™","genericName":"Sevre-Long™","companyName":"Mundipharma Medical Company","companyId":"mundipharma-medical-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sevre-Long™ is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the incretin hormone GLP-1 to regulate glucose metabolism. Used for Type 2 diabetes, Obesity.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}